<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>INDIVIOR 2 RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Tue, 28 Apr 2026 20:01:39 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/indivior%5F2%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>INDIVIOR 2 RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>Indivior Announces Inclusion in the S&amp;P SmallCap 600® Index</title><pubDate>Mon, 22 Dec 2025 13:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/indivior-announces-inclusion-in-the-s-p-smallcap-600-index-15374310</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">RICHMOND, Va., <span class="legendSpanClass"><span class="xn-chron">Dec. 22, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) ("<b>Indivior PLC</b>" or the  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/indivior-announces-inclusion-in-the-s-p-smallcap-600-index-15374310</guid></item><item><title>New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations</title><pubDate>Wed, 17 Dec 2025 17:30:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/new-study-shows-extended-release-buprenorphine-safely-delivers-rapid-clinically-meaningful-reductions-in-opioid-use-and-supports-abstinence-in-high-risk-populations-15365948</link><description><![CDATA[<p><ul type="disc" xmlns="http://www.w3.org/1999/xhtml"><li><i>Both monthly maintenance doses (100 mg and 300 mg) improved opioid abstinence and were well-tolerated with no new safety signals identified.</i></li><li><i>Post-hoc analyses indicated the 300-mg  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/new-study-shows-extended-release-buprenorphine-safely-delivers-rapid-clinically-meaningful-reductions-in-opioid-use-and-supports-abstinence-in-high-risk-populations-15365948</guid></item><item><title>CRH, Carvana and Comfort Systems USA Set to Join S&amp;P 500; Others to Join S&amp;P MidCap 400 and S&amp;P SmallCap 600</title><pubDate>Fri, 05 Dec 2025 23:49:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/crh-carvana-and-comfort-systems-usa-set-to-join-s-p-500-others-to-join-s-p-midcap-400-and-s-p-smallcap-600-15339917</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">NEW YORK, <span class="legendSpanClass"><span class="xn-chron">Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/crh-carvana-and-comfort-systems-usa-set-to-join-s-p-500-others-to-join-s-p-midcap-400-and-s-p-smallcap-600-15339917</guid></item><item><title>Indivior Concludes Legacy U.S. Department of Justice Matter</title><pubDate>Thu, 20 Nov 2025 22:01:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/indivior-concludes-legacy-u-s-department-of-justice-matter-15299269</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">RICHMOND, Va., <span class="legendSpanClass"><span class="xn-chron">Nov. 20, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) today announced the Company has  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/indivior-concludes-legacy-u-s-department-of-justice-matter-15299269</guid></item><item><title>Indivior to Participate in the Piper Sandler 37th Annual Healthcare Conference</title><pubDate>Wed, 19 Nov 2025 15:21:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/indivior-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference-15292069</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">RICHMOND, Va., <span class="legendSpanClass"><span class="xn-chron">Nov. 19, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/indivior-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference-15292069</guid></item><item><title>Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine</title><pubDate>Mon, 03 Nov 2025 14:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/indivior-presents-new-real-world-evidence-at-amcp-nexus-2025-demonstrating-clinical-and-economic-benefits-of-adherence-to-monthly-injectable-buprenorphine-15176166</link><description><![CDATA[<p><ul type="disc" xmlns="http://www.w3.org/1999/xhtml"><li><i>Medicaid and commercially insured patients with high adherence to SUBLOCADE® experienced lower relapse rates and reduced healthcare resource utilization</i></li><li><i>Adherence to SUBLOCADE was associated with lower rates of infectious disease  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/indivior-presents-new-real-world-evidence-at-amcp-nexus-2025-demonstrating-clinical-and-economic-benefits-of-adherence-to-monthly-injectable-buprenorphine-15176166</guid></item><item><title>Indivior mit Zahlen zum abgelaufenen Quartal</title><pubDate>Sat, 01 Nov 2025 06:35:06 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/indivior-mit-zahlen-zum-abgelaufenen-quartal-15161783</link><description><![CDATA[<p><a href="https://www.finanzen.net/aktien/indivior_2-aktie">Indivior</a> hat sich am 30.10.2025 zu den Geschäftsergebnissen des am 30.09.2025 beendeten Quartals geäußert.Das Ergebnis je Aktie lag bei 0,33 USD, nach 0,030 USD im Vorjahresvergleich.Das Unternehmen wies eine Umsatzsteigerung  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/indivior-mit-zahlen-zum-abgelaufenen-quartal-15161783</guid></item><item><title>Indivior Reports Third Quarter 2025 Financial Results and Raises Full-Year 2025 Financial Guidance</title><pubDate>Thu, 30 Oct 2025 12:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/indivior-reports-third-quarter-2025-financial-results-and-raises-full-year-2025-financial-guidance-15147204</link><description><![CDATA[<p><ul type="disc" xmlns="http://www.w3.org/1999/xhtml"><li><i>Q</i>3<i>'25 Total Net Revenue of <span class="xn-money">$314m, up 2% YOY; Q</i>3<i>'25 SUBLOCADE® Net Revenue of <span class="xn-money">$219m, up 15% YOY</i></li><li><i>Announces the Optimization  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/indivior-reports-third-quarter-2025-financial-results-and-raises-full-year-2025-financial-guidance-15147204</guid></item><item><title>Ausblick: Indivior verkündet Quartalsergebnis zum jüngsten Jahresviertel</title><pubDate>Wed, 29 Oct 2025 07:01:07 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/ausblick-indivior-verkuendet-quartalsergebnis-zum-juengsten-jahresviertel-15137571</link><description><![CDATA[<p><a href="https://www.finanzen.net/aktien/indivior_2-aktie">Indivior</a> stellt am 30.10.2025 bei der vierteljährlichen Finanzkonferenz die Zahlen zum jüngsten Quartal vor.Die Schätzungen von 5 Analysten belaufen sich beim EPS auf durchschnittlich 0,392 USD je Aktie. Im Vorjahresquartal  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/ausblick-indivior-verkuendet-quartalsergebnis-zum-juengsten-jahresviertel-15137571</guid></item><item><title>Indivior to Participate in the Stifel 2025 Healthcare Conference</title><pubDate>Tue, 28 Oct 2025 15:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/indivior-to-participate-in-the-stifel-2025-healthcare-conference-15132563</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">RICHMOND, Va., <span class="legendSpanClass"><span class="xn-chron">Oct. 28, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/indivior-to-participate-in-the-stifel-2025-healthcare-conference-15132563</guid></item></channel></rss>
